Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-Phenylanthranilic acid, also known as N-(phenylacetyl)-L-phenylalanine, is an organic compound that belongs to the class of anthranilic acids. It is characterized by the presence of an anthranilic acid moiety attached to a phenylalanine group through an amide bond. This unique structure endows N-Phenylanthranilic acid with a range of applications in various fields.

91-40-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 91-40-7 Structure
  • Basic information

    1. Product Name: N-Phenylanthranilic acid
    2. Synonyms: LABOTEST-BB LT00053431;FENAMIC ACID;DIPHENYLAMINE-2-CARBOXYLIC ACID;2-ANILINOBENZOIC ACID;2-(PHENYLAMINO)BENZOIC ACID;2,2'-IMINODIBENZOIC ACID;AKOS AU36-M185;N-PHENYLANTHRANILIC ACID
    3. CAS NO:91-40-7
    4. Molecular Formula: C13H11NO2
    5. Molecular Weight: 213.23
    6. EINECS: 202-066-8
    7. Product Categories: N/A
    8. Mol File: 91-40-7.mol
  • Chemical Properties

    1. Melting Point: 182-185 °C(lit.)
    2. Boiling Point: 353.22°C (rough estimate)
    3. Flash Point: 186.7 °C
    4. Appearance: Light gray-green/Fine Powder
    5. Density: 1.1544 (rough estimate)
    6. Vapor Pressure: 1.27E-06mmHg at 25°C
    7. Refractive Index: 1.5700 (estimate)
    8. Storage Temp.: Store below +30°C.
    9. Solubility: N/A
    10. PKA: pKa 5.28(5–10%aq. acetone t=25±0.1 I=0.11) (Uncertain)
    11. Water Solubility: insoluble
    12. Merck: 14,7273
    13. BRN: 1456607
    14. CAS DataBase Reference: N-Phenylanthranilic acid(CAS DataBase Reference)
    15. NIST Chemistry Reference: N-Phenylanthranilic acid(91-40-7)
    16. EPA Substance Registry System: N-Phenylanthranilic acid(91-40-7)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36-24/25
    4. WGK Germany: 3
    5. RTECS: CB3730000
    6. TSCA: Yes
    7. HazardClass: IRRITANT
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 91-40-7(Hazardous Substances Data)

91-40-7 Usage

Uses

Used in Pharmaceutical Industry:
N-Phenylanthranilic acid is used as an ion channel (Cl) blocker for the treatment of various diseases, such as cystic fibrosis and chronic obstructive pulmonary disease (COPD). Its ability to block chloride channels helps in reducing the viscosity of mucus, thereby improving lung function and overall respiratory health.
Used in Analytical Chemistry:
N-Phenylanthranilic acid is used as a reagent for the detection of vanadium in steel. It forms a colored complex with vanadium ions, which can be measured spectrophotometrically, providing a sensitive and reliable method for vanadium analysis in steel samples.
Used in Biological Studies:
N-Phenylanthranilic acid is used in biological studies as an inhibitor of aldo-keto reductase 1C3 based on N-phenyl-aminobenzoates. Aldo-keto reductases are a family of enzymes involved in the reduction of aldehydes and ketones, and their inhibition can have potential therapeutic applications in the treatment of various diseases, such as cancer and diabetes.

Safety Profile

Poison by intravenous and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx.

Purification Methods

Crystallise the acid from EtOH (5mL/g) or AcOH (2mL/g) by adding hot water (1mL/g). [Beilstein 14 IV 1019.]

Check Digit Verification of cas no

The CAS Registry Mumber 91-40-7 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 91-40:
(4*9)+(3*1)+(2*4)+(1*0)=47
47 % 10 = 7
So 91-40-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H11NO2/c15-13(16)11-8-4-5-9-12(11)14-10-6-2-1-3-7-10/h1-9,14H,(H,15,16)/p-1

91-40-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A14340)  N-Phenylanthranilic acid, 99%   

  • 91-40-7

  • 25g

  • 424.0CNY

  • Detail
  • Alfa Aesar

  • (A14340)  N-Phenylanthranilic acid, 99%   

  • 91-40-7

  • 100g

  • 1263.0CNY

  • Detail
  • Alfa Aesar

  • (A14340)  N-Phenylanthranilic acid, 99%   

  • 91-40-7

  • 500g

  • 5641.0CNY

  • Detail
  • Fluka

  • (78150)  N-Phenylanthranilicacid  redox indicator for the detection of vanadium, ≥97.0% (T)

  • 91-40-7

  • 78150-10G

  • 374.40CNY

  • Detail
  • Fluka

  • (78150)  N-Phenylanthranilicacid  redox indicator for the detection of vanadium, ≥97.0% (T)

  • 91-40-7

  • 78150-50G

  • 1,302.21CNY

  • Detail
  • Aldrich

  • (144509)  N-Phenylanthranilicacid  98%

  • 91-40-7

  • 144509-25G

  • 402.48CNY

  • Detail
  • Aldrich

  • (78153)  N-Phenylanthranilicacid  technical, ≥95% (T)

  • 91-40-7

  • 78153-100G

  • 313.56CNY

  • Detail

91-40-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name fenamic acid

1.2 Other means of identification

Product number -
Other names N-Phenylanthranilic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:91-40-7 SDS

91-40-7Synthetic route

2-Iodobenzoic acid
88-67-5

2-Iodobenzoic acid

aniline
62-53-3

aniline

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With copper(l) iodide; potassium carbonate In water; N,N-dimethyl-formamide at 100℃; for 1h; Microwave irradiation;100%
With potassium hydroxide; copper In water for 9h; Heating;97%
With sodium acetate; copper (I) acetate In water for 0.5h; Heating;97%
aniline
62-53-3

aniline

ortho-chlorobenzoic acid
118-91-2

ortho-chlorobenzoic acid

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With copper(I) sulfate; potassium carbonate; copper(II) sulfate In water for 0.0833333h; Ullmann condensation; microwave irradiation;98%
With potassium carbonate; copper(II) sulfate for 0.025h; Ullmann condensation; microwave irradiation;98%
With sodium acetate; copper (I) acetate In water for 4h; Heating;91%
aniline
62-53-3

aniline

2-bromobenzoic-acid
88-65-3

2-bromobenzoic-acid

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With sodium acetate; copper (I) acetate In water for 2.5h; Heating;94%
With D-myo-inositol; copper; caesium carbonate In water at 100℃; for 24h;93%
With potassium carbonate; copper(I) oxide; copper In 2-ethoxy-ethanol at 130℃; for 24h;86%
2-phenylaminobenzonitrile
17583-00-5

2-phenylaminobenzonitrile

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With water at 25℃; for 1.5h; Reflux;92.2%
Methyl N-phenylanthranilate
35708-19-1

Methyl N-phenylanthranilate

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With lithium hydroxide; water In tetrahydrofuran; methanol at 20℃; for 12h;82%
Stage #1: Methyl N-phenylanthranilate With potassium hydroxide In ethanol; water for 3h; Inert atmosphere; Reflux;
Stage #2: With hydrogenchloride In ethanol; water pH=2; Inert atmosphere;
76%
With water; potassium hydroxide In ethanol at 100℃; Inert atmosphere;57%
Stage #1: Methyl N-phenylanthranilate With potassium hydroxide In ethanol; water at 20 - 100℃; Inert atmosphere;
Stage #2: With hydrogenchloride In water at 0℃; pH=2; Inert atmosphere;
57%
anthranilic acid
118-92-3

anthranilic acid

chlorobenzene
108-90-7

chlorobenzene

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With di-tert-butyl{2′-isopropoxy-[1,1′-binaphthalen]-2-yl}phosphane; potassium hydroxide; bis(dibenzylideneacetone)-palladium(0) In tert-butyl alcohol at 90℃; for 20h; Inert atmosphere;81%
aniline
62-53-3

aniline

diethylene glycol
111-46-6

diethylene glycol

2-bromobenzoic-acid
88-65-3

2-bromobenzoic-acid

A

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

B

C11H14O5

C11H14O5

Conditions
ConditionsYield
With copper(II) acetate monohydrate; potassium carbonate at 110℃; for 8h; Inert atmosphere;A 68%
B 13%
methyl 2-(methylamino)-2-oxoacetate
54154-11-9

methyl 2-(methylamino)-2-oxoacetate

N-phenyl isatoic anhydride
20877-86-5

N-phenyl isatoic anhydride

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide for 0.5h;65%
anthranilic acid
118-92-3

anthranilic acid

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With sodium nitrite In chloroform for 5h; Heating;1.5%
methyl 2-(N-phenylbenzamido)benzoate
409111-58-6

methyl 2-(N-phenylbenzamido)benzoate

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With alkaline solution
N-Nitrozo-N-phenyl-anthranilic acid
25854-97-1

N-Nitrozo-N-phenyl-anthranilic acid

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With acetic acid; zinc
bromobenzene
108-86-1

bromobenzene

anthranilic acid
118-92-3

anthranilic acid

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With copper; potassium carbonate; nitrobenzene
With copper chloride; i-Amyl alcohol
With copper(l) iodide; i-Amyl alcohol
With copper(l) iodide; copper; potassium carbonate In N,N-dimethyl-formamide at 120℃; for 12h; Inert atmosphere;
2-Iodobenzoic acid
88-67-5

2-Iodobenzoic acid

N-Phenylhydroxylamine
100-65-2

N-Phenylhydroxylamine

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With copper; benzene
n-butyllithium
109-72-8, 29786-93-4

n-butyllithium

diethyl ether
60-29-7

diethyl ether

diphenylamine
122-39-4

diphenylamine

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
anschliessenden Behandeln mit festem Kohlendioxid;
ortho-chlorobenzoic acid
118-91-2

ortho-chlorobenzoic acid

2-bromobenzoic-acid
88-65-3

2-bromobenzoic-acid

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
Erhitzen der Alkalisalze in waessr. Loesung mit Anilin in Gegenwart von Kupferpulver oder Kupfersalzen;
N-phenyl-anthranilic acid-anhydride
52069-22-4

N-phenyl-anthranilic acid-anhydride

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With sodium hydroxide
2-<(1,2-dioxo-2-(methylamino)ethyl)phenylamino>benzoic acid methyl ester
76681-84-0

2-<(1,2-dioxo-2-(methylamino)ethyl)phenylamino>benzoic acid methyl ester

A

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

B

3-phenylimino-2-indolinone
33828-98-7, 101671-27-6

3-phenylimino-2-indolinone

C

Methyl N-methylanthranilate
85-91-6

Methyl N-methylanthranilate

Conditions
ConditionsYield
With PPA at 80 - 90℃; for 2h;A 70.0 mg
B 0.380 g
C 0.180 g
With PPA at 80 - 90℃; for 2h;A 70.0 mg
B 0.380 g
C 180.0 mg
Diphenyliodonium-2-carboxylate
1488-42-2

Diphenyliodonium-2-carboxylate

aniline
62-53-3

aniline

A

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

B

diphenylamine
122-39-4

diphenylamine

Conditions
ConditionsYield
copper diacetate In isopropyl alcohol at 80℃; for 1h;A 66 % Spectr.
B 2.2 % Spectr.
potassium 2-bromobenzoate
16497-87-3

potassium 2-bromobenzoate

aniline
62-53-3

aniline

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With N-ethylmorpholine;; copper diacetate In N,N-dimethyl-formamide at 145℃; for 3h;
anthranilic acid
118-92-3

anthranilic acid

phenol
108-95-2

phenol

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
With tetrahydrofuran; isopentyl nitrite
iodobenzene
591-50-4

iodobenzene

nitrobenzene
98-95-3

nitrobenzene

1H,1H'-2,2'-Biindolylidene-3,3'-dione
482-89-3

1H,1H'-2,2'-Biindolylidene-3,3'-dione

K2CO3

K2CO3

copper-powder

copper-powder

A

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

B

hydroxy-bis-(3-oxo-1-phenyl-indolin-2-yl)-acetic acid

hydroxy-bis-(3-oxo-1-phenyl-indolin-2-yl)-acetic acid

aniline
62-53-3

aniline

ortho-chlorobenzoic acid
118-91-2

ortho-chlorobenzoic acid

chromium powder

chromium powder

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

aniline
62-53-3

aniline

ortho-chlorobenzoic acid
118-91-2

ortho-chlorobenzoic acid

copper

copper

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

sodium carbonate
497-19-8

sodium carbonate

aniline
62-53-3

aniline

ortho-chlorobenzoic acid
118-91-2

ortho-chlorobenzoic acid

K2CO3

K2CO3

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

bromobenzene
108-86-1

bromobenzene

i-Amyl alcohol
123-51-3

i-Amyl alcohol

anthranilic acid
118-92-3

anthranilic acid

copper chloride

copper chloride

potassium carbonate

potassium carbonate

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

bromobenzene
108-86-1

bromobenzene

i-Amyl alcohol
123-51-3

i-Amyl alcohol

anthranilic acid
118-92-3

anthranilic acid

copper iodide

copper iodide

potassium carbonate

potassium carbonate

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

bromobenzene
108-86-1

bromobenzene

anthranilic acid
118-92-3

anthranilic acid

nitrobenzene
98-95-3

nitrobenzene

potassium carbonate

potassium carbonate

copper

copper

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

bromobenzene
108-86-1

bromobenzene

water
7732-18-5

water

anthranilic acid
118-92-3

anthranilic acid

sodium carbonate

sodium carbonate

copper

copper

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Conditions
ConditionsYield
at 160℃; im Druckrohr;
2-Iodobenzoic acid
88-67-5

2-Iodobenzoic acid

N-Phenylhydroxylamine
100-65-2

N-Phenylhydroxylamine

benzene
71-43-2

benzene

copper powder

copper powder

A

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

B

Azobenzene
1227476-15-4

Azobenzene

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

10H-acridin-9-one
578-95-0

10H-acridin-9-one

Conditions
ConditionsYield
With polyphosphoric acid at 120℃; for 3.5h;99%
With boron trifluoride diethyl etherate In neat (no solvent) at 150℃; for 0.0166667h; Solvent; Temperature; Friedel-Crafts Acylation; Microwave irradiation;98%
With polyphosphoric acid at 120℃; under 760.051 Torr; for 4h; Inert atmosphere;98%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

9-Chloroacridine
1207-69-8

9-Chloroacridine

Conditions
ConditionsYield
With trichlorophosphate at 100℃; for 0.025h; Microwave irradiation;98%
With trichlorophosphate at 135 - 140℃; for 2h; Inert atmosphere;96%
With sulfuric acid; trichlorophosphate for 12h; Heating;84%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

triphenylbismuthane
603-33-8

triphenylbismuthane

triphenylbismuth bis(2-phenylaminobenzoate)

triphenylbismuth bis(2-phenylaminobenzoate)

Conditions
ConditionsYield
With H2O2 In diethyl ether; water byproducts: H2O; 2-phenylaminobenzoic acid and 37% aq. soln. of H2O2 added to soln. of BiPh3 in ether; mixt. was kept at 20°C for 18 h; solvent removed; residue washed (hexane); dried;97%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

trichloromethyl chloroformate
503-38-8

trichloromethyl chloroformate

N-phenyl isatoic anhydride
20877-86-5

N-phenyl isatoic anhydride

Conditions
ConditionsYield
In 1,4-dioxane at 20 - 110℃; for 5h;96%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

di(n-butyl)tin oxide
818-08-6

di(n-butyl)tin oxide

({(o-NH(C6H5)-C6H4COO)(CH3CH2CH2CH2)2Sn}2O)2

({(o-NH(C6H5)-C6H4COO)(CH3CH2CH2CH2)2Sn}2O)2

Conditions
ConditionsYield
In not given recrystn. from CH2Cl2;95%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

5,5-dibenzyl-2,3,4,5-tetrahydropyridine
1416767-53-7

5,5-dibenzyl-2,3,4,5-tetrahydropyridine

6,6-dibenzyl-5-phenyl-5,5a,6,7,8,9-hexahydro-11H-pyrido[2,1-b]quinazolin-11-one

6,6-dibenzyl-5-phenyl-5,5a,6,7,8,9-hexahydro-11H-pyrido[2,1-b]quinazolin-11-one

Conditions
ConditionsYield
With 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; N-ethyl-N,N-diisopropylamine In toluene at 90℃; for 20h;95%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

methylmagnesium chloride
676-58-4

methylmagnesium chloride

α,α-Dimethyl-2-(phenylamino)benzolmethanol
73183-55-8

α,α-Dimethyl-2-(phenylamino)benzolmethanol

Conditions
ConditionsYield
In tetrahydrofuran for 4h; Time; Reflux; Inert atmosphere; Large scale;95%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

ethanol
64-17-5

ethanol

ethyl 2-(phenylamino)benzoate
23868-11-3

ethyl 2-(phenylamino)benzoate

Conditions
ConditionsYield
With sulfuric acid for 8h; Reflux;94%
With hydrogenchloride
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

dimethyl sulfate
77-78-1

dimethyl sulfate

Methyl N-phenylanthranilate
35708-19-1

Methyl N-phenylanthranilate

Conditions
ConditionsYield
With potassium carbonate In acetone for 2h; Reflux;94%
With potassium carbonate In acetone at 60℃; for 3h; Inert atmosphere;94%
With potassium carbonate In acetone for 2h; Reflux;92%
With potassium hydroxide
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

methyl iodide
74-88-4

methyl iodide

2-(N-Methyl-N-phenylamino)-benzoic acid
73323-82-7

2-(N-Methyl-N-phenylamino)-benzoic acid

Conditions
ConditionsYield
In tetrahydrofuran; hexane; water93%
With sodium hydroxide
1,10-Phenanthroline
66-71-7

1,10-Phenanthroline

samarium(III) chloride

samarium(III) chloride

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

water
7732-18-5

water

sodium hydroxide
1310-73-2

sodium hydroxide

4C13H10NO2(1-)*2Sm(3+)*2HO(1-)*H2O*C12H8N2

4C13H10NO2(1-)*2Sm(3+)*2HO(1-)*H2O*C12H8N2

Conditions
ConditionsYield
In methanol at 70℃; for 1h; pH=5;93%
methanol
67-56-1

methanol

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

Methyl N-phenylanthranilate
35708-19-1

Methyl N-phenylanthranilate

Conditions
ConditionsYield
Stage #1: methanol; 2-(phenylamino)benzoic acid for 0.166667h; Cooling with ice;
Stage #2: With thionyl chloride at 0 - 90℃; for 12h;
92%
With thionyl chloride at 0 - 90℃; for 12h; Reflux;92%
With thionyl chloride at 0 - 90℃; for 12h;92%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

N-benzyl(but-3-en-2-yl)amine
37857-30-0

N-benzyl(but-3-en-2-yl)amine

N-benzyl-N-(but-3-en-2-yl)-2-(phenylamino)benzamide
1284151-64-9

N-benzyl-N-(but-3-en-2-yl)-2-(phenylamino)benzamide

Conditions
ConditionsYield
Stage #1: 2-(phenylamino)benzoic acid; N-benzyl(but-3-en-2-yl)amine With benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine In dichloromethane for 0.0333333h; Inert atmosphere;
Stage #2: With diisopropyl-carbodiimide In dichloromethane for 22h; Inert atmosphere;
92%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

dimethyl sulfate
77-78-1

dimethyl sulfate

1-(2-anilinophenyl)ethan-1-one
23699-74-3

1-(2-anilinophenyl)ethan-1-one

Conditions
ConditionsYield
With potassium carbonate In acetone for 2h; Reflux;92%
samarium(III) chloride

samarium(III) chloride

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

water
7732-18-5

water

sodium hydroxide
1310-73-2

sodium hydroxide

4C13H10NO2(1-)*2Sm(3+)*2HO(1-)*4.5H2O

4C13H10NO2(1-)*2Sm(3+)*2HO(1-)*4.5H2O

Conditions
ConditionsYield
In methanol at 70℃; for 1h; pH=6-6.5;92%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

para-bromotoluene
106-38-7

para-bromotoluene

4-methyl-2'-(N-phenylamino)biphenyl
911217-14-6

4-methyl-2'-(N-phenylamino)biphenyl

Conditions
ConditionsYield
Stage #1: 2-(phenylamino)benzoic acid With potassium carbonate In various solvent(s) at 120℃; for 0.5h;
Stage #2: para-bromotoluene With [2,2]bipyridinyl; copper(l) iodide In various solvent(s) at 160℃; for 24h; Further stages.;
91%
With potassium carbonate; copper(l) iodide; dipyridyl; bis(acetylacetonato)palladium(II) In 1-methyl-pyrrolidin-2-one at 160℃; for 24h; Product distribution / selectivity; Molecular sieve;91 %Chromat.
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

4,4'-dimethoxydiphenylacetylene
2132-62-9

4,4'-dimethoxydiphenylacetylene

8-(N-phenylamino)-3,4-bis(4-methoxyphenyl)isocoumarin
1147303-99-8

8-(N-phenylamino)-3,4-bis(4-methoxyphenyl)isocoumarin

Conditions
ConditionsYield
With dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer; copper diacetate In o-xylene at 120℃; for 2h;91%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

N-allyl-N-octylamine
2687-93-6

N-allyl-N-octylamine

N-allyl-N-octyl-2-(phenylamino)benzamide
1284151-65-0

N-allyl-N-octyl-2-(phenylamino)benzamide

Conditions
ConditionsYield
Stage #1: 2-(phenylamino)benzoic acid; N-allyloctan-1-amine With benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine In dichloromethane for 0.0333333h; Inert atmosphere;
Stage #2: With diisopropyl-carbodiimide In dichloromethane for 24h; Inert atmosphere;
91%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

2-Methyl-5-phenyl-isoxazolium-methosulfat
114514-93-1

2-Methyl-5-phenyl-isoxazolium-methosulfat

N-Methyl-N-(3-oxo-3-phenyl-propionyl)-2-phenylamino-benzamide
114515-02-5

N-Methyl-N-(3-oxo-3-phenyl-propionyl)-2-phenylamino-benzamide

Conditions
ConditionsYield
With potassium hydroxide In water at -5℃; pH=<9;90%
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

europioum(III) chloride

europioum(III) chloride

water
7732-18-5

water

sodium hydroxide
1310-73-2

sodium hydroxide

5C13H10NO2(1-)*2Eu(3+)*HO(1-)*4.5H2O

5C13H10NO2(1-)*2Eu(3+)*HO(1-)*4.5H2O

Conditions
ConditionsYield
In methanol at 70℃; for 1h; pH=6-6.5;90%
1,10-Phenanthroline
66-71-7

1,10-Phenanthroline

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

europioum(III) chloride

europioum(III) chloride

water
7732-18-5

water

sodium hydroxide
1310-73-2

sodium hydroxide

5C13H10NO2(1-)*2Eu(3+)*HO(1-)*H2O*C12H8N2

5C13H10NO2(1-)*2Eu(3+)*HO(1-)*H2O*C12H8N2

Conditions
ConditionsYield
In methanol at 70℃; for 1h; pH=5;90%
tryptamine
61-54-1

tryptamine

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

N-(2-(1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

N-(2-(1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 5h;90%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 8h;75%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 10h; Inert atmosphere;
5-methyltryptamine
1821-47-2

5-methyltryptamine

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

N-(2-(5-methyl-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

N-(2-(5-methyl-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 5h;90%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 8h;90%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 10h; Inert atmosphere;
2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 5h;90%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 8h;75%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 8h;75%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 10h; Inert atmosphere;
5-chlorotryptamine
3764-94-1

5-chlorotryptamine

2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

N-(2-(5-chloro-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

N-(2-(5-chloro-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 5h;90%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 8h;75%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 10h; Inert atmosphere;
2-(phenylamino)benzoic acid
91-40-7

2-(phenylamino)benzoic acid

1,2-bis(4-methylphenyl)acetylene
2789-88-0

1,2-bis(4-methylphenyl)acetylene

8-(N-phenylamino)-3,4-bis(4-methylphenyl)isocoumarin
1147303-97-6

8-(N-phenylamino)-3,4-bis(4-methylphenyl)isocoumarin

Conditions
ConditionsYield
With dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer; copper diacetate In o-xylene at 120℃; for 2h;89%

91-40-7Relevant articles and documents

Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer

Liang, Ziyi,Lei, Fang,Deng, Jiedan,Zhang, Honghua,Wang, Yuqing,Li, Junfang,Shi, Tao,Yang, Xiaoyan,Wang, Zhen

, (2021/11/22)

Gastric cancer represents a significant health burden worldwide. Previously, inspired by the traditional Chinese medicine Wu-Chu-Yu to treat the spleen and stomach system for thousands of years, we identified N14-phenyl substituted evodiamine derivatives as potential antitumor agents with favorable inhibition on Top1. Herein, structural optimization and structure-activity relationship studies (SARs) led us to discovering a highly active evodiamine derivative compound 6t against gastric cancer. Further anti-tumor mechanism studies revealed that compound 6t played as the inhibition of topoisomerase 1 (Top1), effectively induced apoptosis, obviously arrested the cell cycle at the G2/M phase, and significantly inhibited the migration and invasion of SGC-7901 and MGC-803 cell lines in a dose-dependent manner. Moreover, the compound 6t was low toxicity in vivo and exhibited excellent anti-tumor activity (TGI = 70.12%) in the MGC-803 xenograft models. In summary, compound 6t represents a promising candidate as a potential chemotherapeutic agent against gastric cancer.

Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents

Deng, Jiedan,Hao, Xiangyong,Lei, Fang,Liang, Ziyi,Wang, Yuqing,Wang, Zhen,Yang, Xiaoyan,Zhang, Honghua

, (2022/01/10)

Natural products are important sources for the development of therapeutic medicine, among which evodia fruit has a wide range of medicinal properties in traditional Chinese medicine. Evodiamine, the main active component of evodia fruit, has various anti-cancer effects and has been proved to be a Topo inhibitor. From our previous attempts of modifying evodiamine, we found that the N14 phenyl substituted derivatives had showed great anti-tumor activity, which prompted us to further explore the novel structures and activities of these compounds. Compound 6f, as a N14 3-fluorinated phenyl substituted evodiamine derivative, showed a certain inhibitory activity against Topo I at 200 μM. By studying its anti-tumor effects in vitro, compound 6f could inhibit proliferation and induce apoptosis, as well as arrest the cell cycle of HGC-27 and HT-29 cell lines at G2/M phase in a concentration-dependent manner. Moreover, compound 6f could inhibit the migration and invasion of HGC-27 cell lines. Meanwhile, compound 6f could induce apoptosis of HGC-27 cells by inhibiting PI3K/AKT pathway. Overall, this work demonstrated that the N14 phenyl-substituted evodiamine derivatives had a good inhibitory effect on tumor cells in vitro, providing a promising strategy for developing potential anticancer agents for the treatment of gastrointestinal tumors.

Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents

Song, Di,Zhang, Nan,Zhang, Panpan,Zhang, Na,Chen, Weijin,Zhang, Long,Guo, Ting,Gu, Xiaotong,Ma, Shutao

, (2021/05/10)

With the increasing incidence of antibiotic resistance, new antibacterial agents having novel mechanisms of action hence are in an urgent need to combat infectious diseases caused by multidrug-resistant (MDR) pathogens. Four novel series of substituted 9-arylalkyl-10-methylacridinium derivatives as FtsZ inhibitors were designed, synthesized and evaluated for their antibacterial activities against various Gram-positive and Gram-negative bacteria. The results demonstrated that they exhibited broad-spectrum activities with substantial efficacy against MRSA and VRE, which were superior or comparable to the berberine, sanguinarine, linezolid, ciprofloxacin and vancomycin. In particular, the most promising compound 15f showed rapid bactericidal properties, which avoid the emergence of drug resistance. However, 15f showed no inhibitory effect on Gram-negative bacteria but biofilm formation study gave possible answers. Further target identification and mechanistic studies revealed that 15f functioned as an effective FtsZ inhibitor to alter the dynamics of FtsZ self-polymerization, which resulted in termination of the cell division and caused cell death. Further cytotoxicity and animal studies demonstrated that 15f not only displayed efficacy in a murine model of bacteremia in vivo, but also no significant hemolysis to mammalian cells. Overall, this compound with novel skeleton could serve as an antibacterial lead of FtsZ inhibitor for further evaluation of drug-likeness.

Compound, pharmaceutical composition, medicine and application of compound, pharmaceutical composition and medicine in preparation of antibacterial products

-

Paragraph 0066-0068, (2021/07/17)

The invention particularly relates to a compound, a pharmaceutical composition, a medicine and application of the compound, the pharmaceutical composition and the medicine in preparation of antibacterial products. The seeking of a novel antibacterial target and the development of a novel chemical entity have important significance for solving the increasingly severe bacterial drug resistance problem at present, and the design of a compound entity acting on the FtsZ target is expected to be developed to obtain an antibacterial drug which has no influence on a host. The invention provides a 9-aralkyl-10-methylacridine quaternary ammonium salt derivative and a preparation method thereof, and the compound has significant bactericidal and/or bacteriostatic activity on gram-positive bacteria, has a good effect of inhibiting bacterial division protein FtsZ, and can be used for preparing antibacterial products.

Aromatic heterocycle substituted acridine quaternary ammonium salt derivative as well as preparation method and application thereof

-

Paragraph 0067-0070, (2021/09/29)

The invention belongs to the technical field of pharmaceutical compounds, relates to an aromatic heterocyclic substituted acridine quaternary ammonium salt derivative and a preparation method and application thereof, and has the structure shown in a formula (I). In-flight R1 A compound selected from the group consisting of aryl and heteroaryl. Substituted aryls. X Is a halogen or benzenesulfonate anion. The invention provides an aromatic heterocyclic substituted acridine quaternary ammonium salt derivative as well as a preparation method and application thereof, and is designed to synthesize an aromatic heterocyclic substituted acridine quaternary ammonium salt derivative through a simplified structure, and is designed to synthesize an aromatic heterocyclic substituted acridine quaternary ammonium salt derivative so as to achieve the unique antibacterial effect by inhibiting the bacteria FtsZ and bacterial biofilm.

Synthesis, antibacterial evaluation and computational studies of new acridone-1,2,3-triazole hybrids

Aarjane, Mohammed,Amine, Amina,Slassi, Siham

, (2021/06/07)

In continuation of our efforts to develop new drugs with antibacterial properties we have synthesized and evaluated new 1,2,3-triazole derivatives from acridone. The synthetic approach was started by the preparation of acridone skeleton through the Ullman condensation of 2-bromobenzoic acid and aniline derivatives. Subsequently, acridone nucleus was functionalized with propargyl bromide. Then, a click reaction of the latter compound and aromatic azides led to the formation of the title compounds in good yields. The synthesized compounds were screened for their in vitro antibacterial activity against one gram-positive bacteria S. aureus and three gram-negative bacteria P. putida, K. pneumoniae and E. coli. Among the synthesized compounds, 2-methyl-10-((1-(o-tolyl)-1H-1,2,3-triazol-4-yl)methyl)acridone (4e) had the most potent inhibitory activity against S. aureus with MIC = 10.1 μg/mL. Then, in silico docking studies were used in order to understand the binding interactions and mode of action of these compounds.

Development of LM98, a Small-Molecule TEAD Inhibitor Derived from Flufenamic Acid

Mélin, Léa,Abdullayev, Shuay,Fnaiche, Ahmed,Vu, Victoria,González Suárez, Narjara,Zeng, Hong,Szewczyk, Magdalena M.,Li, Fengling,Senisterra, Guillermo,Allali-Hassani, Abdellah,Chau, Irene,Dong, Aiping,Woo, Simon,Annabi, Borhane,Halabelian, Levon,LaPlante, Steven R.,Vedadi, Masoud,Barsyte-Lovejoy, Dalia,Santhakumar, Vijayaratnam,Gagnon, Alexandre

, p. 2982 - 3002 (2021/08/03)

The YAP-TEAD transcriptional complex is responsible for the expression of genes that regulate cancer cell growth and proliferation. Dysregulation of the Hippo pathway due to overexpression of TEAD has been reported in a wide range of cancers. Inhibition of TEAD represses the expression of associated genes, demonstrating the value of this transcription factor for the development of novel anti-cancer therapies. We report herein the design, synthesis and biological evaluation of LM98, a flufenamic acid analogue. LM98 shows strong affinity to TEAD, inhibits its autopalmitoylation and reduces the YAP-TEAD transcriptional activity. Binding of LM98 to TEAD was supported by 19F-NMR studies while co-crystallization experiments confirmed that LM98 is anchored within the palmitic acid pocket of TEAD. LM98 reduces the expression of CTGF and Cyr61, inhibits MDA-MB-231 breast cancer cell migration and arrests cell cycling in the S phase during cell division.

Novel series of N-acylhydrazone based on acridone: Synthesis, conformational and theoretical studies

Aarjane, Mohammed,Amine, Amina,Slassi, Siham

, (2020/08/22)

In this work, novel N-acylhydrazone derivatives from acridone have been synthesized by condensation of 9-oxoacridin-10(9H)-yl)acetohydrazide with various aldehyde and ketone. The structures of these novel compounds were elucidated by 1H NMR, 13C NMR, IR and mass spectroscopy. The NMR data shows two conformations (E, trans and E, cis) due to N–C(O) bond rotation, the conformations of synthesized compounds have been investigated by different NMR methods. The rotational barriers around N–C(O) bond for compound 5a was measured in DMSO using dynamic NMR spectroscopy, this result was confirmed by DFT calculations at B3LYP/6–31 G (d) level in DMSO.

Synthesis and biological evaluation of novel isoxazole derivatives from acridone

Aarjane, Mohammed,Slassi, Siham,Tazi, Bouchra,Amine, Amina

, (2020/12/07)

The present study was carried out in an?attempt to synthesize a new class of potential antibacterial agents. In this context, novel isoxazoles were synthesized and evaluated for their potential antibacterial behavior against four pathogenic bacterial strains. The synthesized compounds exhibited moderate-to-good antibacterial activity against these strains. The highest antibacterial activity was observed against the Escherichia coli strains, particularly for compounds 4a and 4e with phenyl and para-nitrophenyl groups on the isoxazole–acridone skeleton;?they showed promising minimum inhibitory concentration values of 16.88 and 19.01 μg/ml, respectively, compared with the standard drug chloramphenicol (22.41 μg/ml). The synthesized compounds were subjected to in silico docking studies to understand the mode of their interactions with the DNA topoisomerase complex (PDB ID: 3FV5) of E. coli. The molecular docking results showed that compounds 4a–l occupy the active site of DNA topoisomerase (PDB ID: 3FV5), stabilized via hydrogen bonding and hydrophobic interactions, which may be the reason behind their interesting in vitro antibacterial activity.

Synthesis, spectroscopic characterization (FT-IR, NMR) and DFT computational studies of new isoxazoline derived from acridone

Aarjane, Mohammed,Slassi, Siham,Ghaleb, Adib,Amine, Amina

, (2021/01/28)

In this study, a new isoxazoline derived from acridone, 10‐{[3‐(4‐chlorophenyl)‐4,5‐dihydro‐1,2‐oxazol‐5 yl]methyl} acridone (3) was successfully synthesized and characterized by FT-IR, 1H NMR, 13C NMR and HRMS. The preparation of compound (3) was achieved by 1,3-dipolar cycloaddition reaction between 4?chloro-N-hydroxybenzimidoyl chloride and 10-allylacridone using environment friendly methods. In an effort to complete the chemical structure description of the synthetized compound, Density Functional Theory (DFT) was applied using Gaussian09 and Gaussian view5 programs. The theoretical calculations were used as a compliment to the experimental studies. The computing of geometric parameters, optimization energies, frontier molecular orbital energies, Molecular surface electrostatic potential (MESP) and Mulliken charges were calculated using DFT/B3LYP method with 6–31G(d,p) as basis set. The Infrared vibrational frequencies and 1H and 13C NMR chemical shifts were also calculated and their scaled values are in agreement with the experimental results.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 91-40-7